<PAGE> 1
[ALLERGAN, INC. LETTERHEAD]
Jeffrey L. Edwards
Vice President, Treasurer
February 4, 1998
VIA EDGAR TRANSMISSION
Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington, D.C. 20549
RE: ALLERGAN, INC. ("ALLERGAN")
REGISTRATION STATEMENT ON FORM S-3 (NO. 333-44031)
APPLICATION FOR WITHDRAWAL
Ladies and Gentlemen:
The undersigned registrant hereby makes application, pursuant to paragraph (a)
of Rule 477 under the Securities Act of 1933, as amended, to withdraw the
above Registration Statement. This application is made on the grounds that the
above Registration Statement is not necessary in light of the change in the
terms of the transaction eliminating the ability to exercise the Class A Common
Stock Purchase Option using shares of Allergan Common Stock.
If you should have any questions regarding this application, please contact
Thomas A. Coll or Jane K. Adams of Cooley Godward LLP at (619) 550-6000.
Sincerely,
ALLERGAN, INC.
/s/ JEFFREY L. EDWARDS
- ----------------------------------
cc: M. Kathleen Haller, Esq.
Francis R. Tunney, Jr., Esq.
Thomas A. Coll, Esq.
Jane K. Adams, Esq.
